InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: CATTDOGG12347 post# 27123

Saturday, 07/22/2017 11:45:09 AM

Saturday, July 22, 2017 11:45:09 AM

Post# of 108192
“We look forward to our continued work with Advaxis to explore the ground-breaking potential of ADXS-NEO in the clinic and across multiple tumor types,” said David Reese, Amgen’s senior vice president for Translational Sciences.

I'm not sure what Amgen has in mind for cancer types but I would think they would go for those that would garner the largest market, breast, lung, etc. Just my thought.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News